[go: up one dir, main page]

AU2001230605A1 - Apoptosis inhibitor - Google Patents

Apoptosis inhibitor

Info

Publication number
AU2001230605A1
AU2001230605A1 AU2001230605A AU3060501A AU2001230605A1 AU 2001230605 A1 AU2001230605 A1 AU 2001230605A1 AU 2001230605 A AU2001230605 A AU 2001230605A AU 3060501 A AU3060501 A AU 3060501A AU 2001230605 A1 AU2001230605 A1 AU 2001230605A1
Authority
AU
Australia
Prior art keywords
apoptosis inhibitor
apoptosis
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230605A
Inventor
Hisashi Oku
Ryuji Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001230605A1 publication Critical patent/AU2001230605A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001230605A 2000-02-09 2001-02-09 Apoptosis inhibitor Abandoned AU2001230605A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000038048 2000-02-09
JP2000/38048 2000-02-09
PCT/JP2001/000935 WO2001058448A1 (en) 2000-02-09 2001-02-09 Apoptosis inhibitor

Publications (1)

Publication Number Publication Date
AU2001230605A1 true AU2001230605A1 (en) 2001-08-20

Family

ID=18561852

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230605A Abandoned AU2001230605A1 (en) 2000-02-09 2001-02-09 Apoptosis inhibitor

Country Status (2)

Country Link
AU (1) AU2001230605A1 (en)
WO (1) WO2001058448A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of agents that inhibit the activity of intracellular elastase in the preparation of a medicament for treating and/or preventing necrosis of cells and diseases associated therewith
JP4542743B2 (en) 2002-12-26 2010-09-15 Ｋｄｌ株式会社 Solution pharmaceutical composition of pyridone derivatives
WO2005047256A1 (en) 2003-11-14 2005-05-26 Shanghai Genomics, Inc. The derivatives of pyridone and the use of them
ES2365617T3 (en) 2003-11-25 2011-10-07 Virginia Tech Intellectual Properties, Inc. COMPOSITION FOR CONSUMPTION IN ANIMALS AND METHOD TO REDUCE THE ACTIVITY OF MAP QUINASA.
US20060094753A1 (en) * 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
US7728013B2 (en) 2005-05-10 2010-06-01 Intermune, Inc. Method of modulating stress-activated protein kinase system
CZ297528B6 (en) * 2005-06-10 2007-01-03 Výzkumný ústav živočišné výroby Use of MAP kinase JNK inhibitor for preparing culture medium for prolongation of life of mammalian oocytes in vitro
CA2633980A1 (en) 2005-12-29 2007-07-12 Anthrogenesis Corporation Improved composition for collecting and preserving placental stem cells and methods of using the composition
CA2656017C (en) * 2006-06-15 2014-02-04 Shanghai Genomics, Inc. Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries
ES2567283T3 (en) 2008-06-03 2016-04-21 Intermune, Inc. Compounds and methods to treat inflammatory and fibrotic disorders
WO2010065755A1 (en) 2008-12-04 2010-06-10 Concert Pharmaceuticals, Inc. Deuterated pyridinones
AR092742A1 (en) 2012-10-02 2015-04-29 Intermune Inc ANTIFIBROTIC PYRIDINONES
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
WO2019108551A1 (en) * 2017-11-28 2019-06-06 Eiger Biopharmaceuticals, Inc. Methods and pharmaceutical compositions for the treatment of non-alcoholic steatohepatitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1049411A (en) * 1972-12-18 1979-02-27 Affiliated Medical Research N-substituted pyridone and general method for preparing pyridones
ES2220975T3 (en) * 1995-03-03 2004-12-16 Solomon B. Margolin TREATMENT OF DISORDERS PRODUCED BY CYTOKIN GROWTH FACTORS.
CA2232191C (en) * 1995-09-19 2011-03-15 Solomon B. Margolin Inhibition of tumor necrosis factor alpha

Also Published As

Publication number Publication date
WO2001058448A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU2001262847A1 (en) Language-understanding
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001258349A1 (en) Bisacylguanidine
AU2001230605A1 (en) Apoptosis inhibitor
AUPP982399A0 (en) Mmp inhibitor
AU2001258255A1 (en) Substituted benzoylcyclohexenones
AU2001265871A1 (en) Substituted sulfonylaminopyrimidines
AU2001258924A1 (en) Microsatellite-aflp
AU2001244562A1 (en) Neovascularization inhibitors
AU2001254731A1 (en) Substituted phenyluracils
AU2002349621A1 (en) Angiogenesis inhibitor
AU3955101A (en) Apoptosis inhibitor
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001282520A1 (en) Grk inhibitor
AU2002223604A1 (en) Substituted phenyluracils
AU2001262711A1 (en) Cytoprotectors
AU2001269121A1 (en) Substituted amidoalkyl-uracils as parp inhibitors
AU2001260192A1 (en) Glycinamides
AU3679800A (en) Apoptosis inhibitors